Thursday Jan 11, 2024
Meeting the Heroes Building Therapies for Genetic Diseases
Matthew Gantz is President and Chief Executive Officer of Castle Creek Biosciences, Inc., and he is our guest on this amazingly informative episode. Matt is an accomplished life sciences executive with more than 25 years of experience in the specialty biopharmaceutical and medical device industries.
He shares his perspective about the work and research that is going on to help in the fight for treatments and a cure for Epidermolysis Bullosa (EB). He also talks about the importance of learning all that he can about the children and families affected by this rare and life-threatening skin disorder.
IMPORTANT LINKS AND MORE ABOUT THE VOICES IN THIS EPISODE:
Castle Creek Biosciences, Inc., is a late-stage cell and gene therapy company developing therapies for genetic diseases. Our scientists create optimal therapies that address the distinctive needs of each targeted indication, with an initial focus on skin and connective tissue disorders.